Doug Godshall - Galvanize Therapeutics®
Skip to the content
MENU
Headshot of Doug Godshall, Chairman and CEO

Doug Godshall

Chairman and CEO, Galvanize Therapeutics, Inc.

Doug Godshall was appointed Chief Executive Officer and Chairman of Galvanize in 2025. He served in his prior role as President and CEO of Shockwave Medical until its sale to Johnson & Johnson in 2024 for $13.1B. He is also the former CEO and Director of HeartWare, which was acquired by Medtronic in 2016 for $1.1B. Prior to HeartWare, Doug held executive and leadership positions at Boston Scientific. Doug also serves on the Board of Saluda Medical and is Chairman of the Medical Device Manufacturers of America (MDMA). He earned an MBA from Northeastern University and a BA in Economics from Lafayette College.

Back to the team

Important Notice:

Galvanize Therapeutics® is a medical device manufacturer, not a healthcare provider. The information submitted through this form will be used solely to connect you with a physician in your area who uses the Aliya® PEF System. Please do not submit protected health information (PHI) — including diagnosis, treatment history, or medical records — through this form.

The Aliya® PEF System (K212871, K233884, and K253826) is 510(k) cleared in the United States for the surgical ablation of soft tissue. Galvanize Therapeutics® does not promote the off-label use of its products and nothing herein is intended to promote an off-label use of the Aliya PEF System. The Aliya PEF System is a tool for the surgical ablation of soft tissue it is not intended to treat, cure, prevent, nor mitigate any specific disease or condition.

For questions about coverage or eligibility for this procedure, please consult your physician and insurance provider.

I Understand